Navigation Links
Stem Cell Markets - New Market Report
Date:11/5/2013

nical Trials, 2013 113
Figure 8.11: Vectors Used in Gene Therapy Clinical Trials, 2013 114
Figure 8.12: Gene Types Transferred in Gene Therapy, 2013 114
Figure 8.13: Number of Gene Therapy Clinical Trials Approved Worldwide, 1989-2012 115
Figure 9.1: Cell Therapy Industry Sectors 117
Figure 9.2: Tissue Engineering Companies Worldwide, 2013 119
Figure 9.3: Percent of Public vs. Private TE Companies Worldwide 120
Figure 9.4: Cell and Tissue Banks Breakdown 122
Figure 9.5: AAB and FACT Accredited Cord Blood Banks by Geography, 2013 122
Figure 9.6: Breakout of Spending for Preclinical Studies by Product Platform 125
Figure 9.7: Breakout of Spending for TE and Stem Cell Clinical Trials 125
Figure 9.8: Breakout of Spending for Commercial TE and Stem Cell Products 126
Figure 9.9: Breakout of Spending for TE and Stem Cell Services 126
Figure 9.10: Spending by TE and Stem Cell Therapeutics Developmental Stages by Total Spending 127
Figure 9.11: Number of TE and Stem Cell Companies by Stage of Development 128
Figure 9.12: Geographical Distribution of Spending for TE and Stem Industry 128
Figure 9.13: Total Number of Cell Therapy and Regenerative Medicine Companies by Continent 131
Figure 9.14: Number of Cell Therapy and Regenerative Medicine SMEs in Selected European Countries 132
Figure 9.15: European Stem Cell SMEs by Type and Tissue Source 133
Figure 9.16: European Somatic SMEs by Type and Tissue Source 133
Figure 9.17: Concentration of European Cell Therapy Firms, 2012 134
Figure 9.18: European Stem Cell Platforms by Cell Source 134
Figure 9.19: Stem Cell Therapy by Type in Europe 135
Figure 9.20: Somatic Cell Therapy by Type in Europe 136
Figure 10.1: Indicator of Frequency of General Usage of the Terms “Tissue Engineering,” “Regenerative Medicine” and “Cell Therapy”, 2003-2011 137
Figure 10.2: The
'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Related medicine news :

1. Biosimulation Market (For Drug Discovery & Development) Worth $1.2 Billion by 2017 - New Report by MarketsandMarkets
2. Geosynthetics Market (Geotextile, Geomembrane, Geogrid, Geofoam, Geonet) Volume Worth 5.6 Billion Meter Square by 2018 - New Report by MarketsandMarkets
3. Customer Experience Management Market (Network Types, Touch Points, Verticals) Worth $6.61 Billion by 2017 - New Report by MarketsandMarkets
4. Bring-Your-Own-Device Market (Mobile Device Management, Mobile Application Management) Worth $181.39 Billion by 2017 - New Report by MarketsandMarkets
5. Pressure Sensor Market (Piezoresistive, Capacitive, Electromagnetic, Resonant Solid State, Optical) Worth $7.34 Billion by 2017 - New Report by MarketsandMarkets
6. Breast Imaging Technologies Market (Digital Mammography, 3D Breast Tomosynthesis, Breast MRI) Worth $5 Billion - 2017 - New Report by MarketsandMarkets
7. Biofuels (Bioethanol & Biodiesel) Production in Top and Emerging Countries will be 150,975 Million Liters in 2016 - New Report by MarketsandMarkets
8. Acoustic Wave Sensor Market (SAW And BAW) Worth $721.13 Million - Global Forecast by 2018 - New Report by MarketsandMarkets
9. Cloud Radio Access Network (CLOUD RAN) Market (Components and Services) worth $11.31 Billion by 2018 - New Report by MarketsandMarkets
10. Infection Control Market (Sterilization and Disinfection) Worth $14.0 Billion by 2017- New Report by MarketsandMarkets
11. Aqua Feed Market (Antibiotics, Vitamins, Antioxidants, Amino Acids, Feed Enzymes, Feed Acidifiers) Worth $106 Billion By 2018 - New Report by MarketsandMarkets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... ... June 29, 2015 , ... Healthpointe, ... surgeon, Dr. John A. Mitamura, MD., PhD into their world-class multidisciplinary team of ... including Long Beach , Irwindale and La Tijera-Los Angeles. , Orthopedic ...
(Date:6/29/2015)... , ... June 29, 2015 , ... ... news that the European Medicines Agency (EMA) has granted accelerated approval of Bristol-Myers ... a global public health threat and the approval of nivolumab for patients with ...
(Date:6/29/2015)... ... June 29, 2015 , ... ... announces the Fresh Plus Diaper, a baby invention that makes parenthood less tiring ... projected to reach a market value of USD 52.2 billion in 2017," says ...
(Date:6/29/2015)... ... June 29, 2015 , ... Two ... against C.R. Bard, Inc. and Ethicon, Inc. continue to move forward in New ... Management Conference is to be convened on Thursday, July 23rd at 12:00 p.m. ...
(Date:6/29/2015)... MD (PRWEB) , ... June 29, 2015 , ... OR ... features a revitalized look and feel, as well as a redesigned logo and weekly ... used to, but is now more user-friendly and easier to navigate. , In ...
Breaking Medicine News(10 mins):Health News:Renowned Orthopedic and Spine Surgeon Joins Healthpointe in Long Beach 2Health News:Renowned Orthopedic and Spine Surgeon Joins Healthpointe in Long Beach 3Health News:Society for Immunotherapy of Cancer Reacts to EMA Approval of Nivolumab for Treatment of Metastatic Melanoma 2Health News:Society for Immunotherapy of Cancer Reacts to EMA Approval of Nivolumab for Treatment of Metastatic Melanoma 3Health News:Bringing Up Baby...Millenials Should Check World Patent Marketing's New Baby Invention 2Health News:Bringing Up Baby...Millenials Should Check World Patent Marketing's New Baby Invention 3Health News:Bringing Up Baby...Millenials Should Check World Patent Marketing's New Baby Invention 4Health News:Bringing Up Baby...Millenials Should Check World Patent Marketing's New Baby Invention 5Health News:Transvaginal Mesh Lawsuit News: New Jersey Court Overseeing Thousands of Ethicon, C.R. Bard Pelvic Mesh Claims Schedules July Conference 2Health News:Transvaginal Mesh Lawsuit News: New Jersey Court Overseeing Thousands of Ethicon, C.R. Bard Pelvic Mesh Claims Schedules July Conference 3Health News:Transvaginal Mesh Lawsuit News: New Jersey Court Overseeing Thousands of Ethicon, C.R. Bard Pelvic Mesh Claims Schedules July Conference 4Health News:OR Manager Launches New Website 2
... light, scientists from the National Institute of Standards and Technology ... they can detect molecules that may be markers for diseases ... yet to be tested in clinical trials, it may someday ... sampling their breath, according to the research team from JILA, ...
... in Baltimore ... market, ... announced that Medifast Franchise Systems has sold its,first franchise of Medifast Weight ... Control Centers in the Greater,Baltimore Metropolitan Area., The entire build-out process ...
... RELEASE , Fighting fat bloom can mean ... Agricultural and Food Chemistry , Chemists in England and ... boxes of Valentines Day chocolates, and other goodies, looking fresher ... films on the outside of chocolate, is scheduled for the ...
... Uninsured, those on Medicaid more likely to be diagnosed ... Feb. 18 (HealthDay News) -- People who either have ... likely to be diagnosed with advanced cancers than people ... Cancer Society report. , At a time when more ...
... - the ,Must Join, Social Networking Web Site ... Crystal Light beverage,brand has partnered with actress and musical ... Web site that will help women,harness the power of ... for one another -- to empower, inspire, challenge and,sustain ...
... Hospital,this week opens a new 16-bed inpatient behavioral health ... -- with an innovative way of caring for patients.,Psychiatrists ... continuity and a better experience for patients., The ... for,patients once they arrive in the emergency department throughout ...
Cached Medicine News:Health News:Scientists using laser light to detect potential diseases via breath samples, says new study 2Health News:Scientists using laser light to detect potential diseases via breath samples, says new study 3Health News:Medifast Franchise Systems Sells First Territory in Baltimore 2Health News:Medifast Franchise Systems Sells First Territory in Baltimore 3Health News:American Chemical Society's Weekly PressPac -- Feb. 13, 2008 2Health News:American Chemical Society's Weekly PressPac -- Feb. 13, 2008 3Health News:American Chemical Society's Weekly PressPac -- Feb. 13, 2008 4Health News:American Chemical Society's Weekly PressPac -- Feb. 13, 2008 5Health News:American Chemical Society's Weekly PressPac -- Feb. 13, 2008 6Health News:American Chemical Society's Weekly PressPac -- Feb. 13, 2008 7Health News:American Chemical Society's Weekly PressPac -- Feb. 13, 2008 8Health News:American Chemical Society's Weekly PressPac -- Feb. 13, 2008 9Health News:Timely Cancer Diagnosis Linked to Insurance Status 2Health News:Timely Cancer Diagnosis Linked to Insurance Status 3Health News:Crystal Light and Mandy Moore Launch Unique Online Wellness Community for Women 2Health News:Crystal Light and Mandy Moore Launch Unique Online Wellness Community for Women 3Health News:Regions Hospital to Open New Inpatient Behavioral Health Unit 2
(Date:6/29/2015)... , June 29, 2015  Isis Pharmaceuticals, Inc. (NASDAQ: ... added to the Russell 1000 Index, effective June 26, ... the large-cap segment of the U.S. equity universe. It ... includes approximately 1000 of the largest securities based on ... membership. "We are pleased to be added ...
(Date:6/29/2015)... Axxess , an industry leader in ... vendor accredited by the American Nursing Credentialing Center – ... agencies select the right revenue cycle management (RCM) system ... business. Research by American Health Information Management ... a decrease in productivity of 54.4 - 69 percent ...
(Date:6/29/2015)... 29, 2015  Arbor Solution has added another ... high-powered, multi-functional M2150 offers two platforms: ... Core i5-4402E 1.6 GHz processor and i5-4422E ... and computing performance. Integrated Intel® HD Graphics 4600 ... suited for graphics-intense applications in operating rooms, clinical ...
Breaking Medicine Technology:ISIS Pharmaceuticals Promoted to the Large-Cap Russell 1000 Index 2ISIS Pharmaceuticals Promoted to the Large-Cap Russell 1000 Index 3Axxess Releases eGuide for Home Health Agencies, Revenue Cycle Management: What You Must Do Now - to Succeed! 2Arbor Solution Introduces Multi-Function Medical Workstation with Large 21.5" True Flat Touch Screen 2Arbor Solution Introduces Multi-Function Medical Workstation with Large 21.5" True Flat Touch Screen 3
... N.J., July 05, 2007 /PRNewswire/ -- Results ... open-label, Phase,3 study showed that 77 percent ... 600 mg tablets with,100 mg ritonavir (PREZISTA/r) ... of antiretroviral (ARV) agents, reached a,plasma viral ...
... 2007 - ZIOPHARM,Oncology, Inc. (NASDAQ: ZIOP) announces ... II trial of ZIO-201 (isophosphoramide mustard,- IPM) ... at the,European Society of Medical Oncology (ESMO) ... The abstract entitled, "Phase-I/II,Study of IPM (ZIO-201) ...
Cached Medicine Technology:New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 2New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 3New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 4New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 5New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 6New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 7New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 8Positive ZIO-201 Interim Phase II Sarcoma Data Presented at,European Society for Medical Oncology 2Positive ZIO-201 Interim Phase II Sarcoma Data Presented at,European Society for Medical Oncology 3
Nordan tying forceps, straight, titanium, 6.5 mm tying platforms....
Harms-Tuebingen tying forceps, straight, 6 mm tying platforms....
Castroviejo straight tying forceps, straight shafts, 5 mm tying platforms, wide handle....
Shepard tying forceps, round curved platform 8 mm, 8.5 cm....
Medicine Products: